Idsa Foundation

The microbial pathogenesis in alzheimer's disease program (alz/id) was launched to support innovative Research that may link infectious diseases and alzheimer's disease. This Research includes basic, clinical and/or non-traditional Research approaches across a wide range of disciplines including neurology, microbiology, pathology, virology, and bacteriology. In 2022, Idsa Foundation received grants totaling $3.3 million to fund Research awards for this program. In 2023, awards of approximately $2.5 million were granted to researchers, in addition to other incurred expenses related to the program. Due to the requirements of generally accepted accounting principles (gaap), the timing of the revenue and expense recognition created a large surplus in 2022 and a large deficit in 2023. In 2023, the program launched the first microbial pathogenesis in alzheimer's disease symposium, provided ongoing assistance and monitoring for existing grantees.

Hiv clinical fellowship programhiv clinical fellowship program - the goal of the hiv clinical fellowship program is to provide non-id trained physicians with the most updated best practices for treating patients living with hiv. Clinical training includes management of antiretroviral therapy, treating common co-infectious and comorbidities and multidisciplinary team-based care. Fellows are supported for up to two years during which time they manage the care of a minimum of 30 patients, under the supervision of an hiv medical association mentor. In 2023, one fellow was funded with a $120,436 award.

G.e.r.m.germ - the germ program was developed to provide medical students with mentored clinical learning and/or Research experience in infectious diseases-related topics, including hiv. In 2023, 91 people applied to the germ program and 51 $4,000 grants were awarded totaling $204,000. The goal of the g.e.r.m. Program is to increase interest among undergraduate medical students, particularly among populations underrepresented in medicine, in pursuing id fellowship post-graduate training or a career in hiv medicine by providing mentor-based Research or clinical training; improving analytic, Research and clinical skills of medical students; increasing the number and diversity of the id/hiv Research and clinical workforce. Eligible applicants included first-, second-, and third year medical students and those in combined degree programs (md/mph, md/phd) from accredited allopathic or osteopathic medical schools in the u.s. Applications were reviewed and scored by an expert panel of infectious disease specialists.

Idea incubatorthe idea incubator program is a pitch-style competition for innovations in the field of infectious diseases. The program encourages innovators with original inventions, products and ideas that can improve infectious disease care to apply. Innovations are shared with the id community and judged by individuals from businesses, medical and technology fields. Three winning individuals/teams are selected from those that apply. Finalists present their innovations at the annual idweek conference and are awarded first- ($10,000), second- ($5,000), and third- ($2,500) place prizes. In 2023, Idsa held the first people's choice competition, which collected votes from idweek attendees and others. One innovator was awarded the people's choice award.

Mentorshipthe idweek mentorship program offers opportunities for mentorship and networking through one-on-one interactions between leaders in the field and fellows, residents and medical students during idweek.